ReviewChest2020
Coronavirus Disease 2019 and Smoking: How and Why We Implemented a Tobacco Treatment Campaign.
Review in Chest, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 23 citations in OpenAlex.
- Changes in National Prescribing Trends of Pharmacotherapy to Treat Tobacco and Nicotine Dependence in Relationship to the COVID-19 Pandemic.CHEST pulmonary · 2024Article
- Influence of smoking history on the evolution of hospitalized in COVID-19 positive patients: results from the SEMI-COVID-19 registry.Medicina clinica · 2022Observational
- Influence of smoking history on the evolution of hospitalized in COVID-19 positive patients: Results from the SEMI-COVID-19 registry.Medicina clinica (English ed.) · 2022Article
- The Effect of COVID-19 on Smoking and Vaping Rates.Annals of the American Thoracic Society · 2022Article
- Impact of the COVID-19 pandemic on smoking behavior and beliefs among the American University of Beirut community.Tobacco prevention & cessation · 2022Article
- Cross-Sectional Survey of Smoking Patterns During the COVID-19 Pandemic in a Tobacco Cessation and Lung Cancer Screening Program.Ochsner journal · 2022Article
- Health Inequalities During COVID-19 and Their Effects on Morbidity and Mortality.Journal of healthcare leadership · 2021Review
- Antecedents and Consequences of Smoking Cessation Intention in the Context of the Global COVID-19 Infodemic.Frontiers in public health · 2021Article
- COVID-19 and smoking: A comment.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2021Article
- Impact of Smoking on Women During the Covid-19 Pandemic.Frontiers in medicine · 2021Review
- More Than Meets the Eye: The Similarities Between Coronavirus Disease 2019 and Smoking.Mayo Clinic proceedings · 2020Article
- Tobacco and e-cigarette shops awarded 'essential business' labels in France during COVID-19.Tobacco induced diseases · 2020Article
- System-Level Quality Improvement Initiatives for Tobacco Use in a Safety-Net Health System During the COVID-19 Pandemic.Journal of primary care & community healthArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Smoking is associated with one of five deaths in the United States. Multimodality tobacco treatment increases rates of successful cessation by at least 20%. The coronavirus disease 2019 pandemic has put a halt to many inpatient and outpatient medical visits that have been deemed nonessential, including tobacco treatment. The transition to telehealth has been wrought with challenges. Although data on the association between coronavirus disease 2019 and tobacco products are mixed, the overall health consequences of tobacco point towards increased risk of morbidity and death that is associated with the virus. This leaves smoking as one of the few readily modifiable risk factors in an environment understandably not set up to prioritize cessation. A military health facility on Fort Eustis in Virginia runs a successful tobacco treatment program and adapted it to pandemic times. This article describes the process and lessons learned from this initiative. The model is applicable and scalable to government and civilian health centers as health care adapts to a new normal.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.